Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Muenst, S. ; Schaerli, A. R. ; Gao, F. ; Däster, S. ; Trella, E. ; Droeser, R. A. ; Muraro, M. G. ; Zajac, P. ; Zanetti, R. ; Gillanders, W. E. ; Weber, W. P. ; Soysal, S. D.

Breast cancer research and treatment, 2014-07, Vol.146 (1), p.15-24 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível